COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Optimizing Pulsatility During Cardiopulmonary Bypass

Recruiting

Conditions: Endothelial Dysfunction
Acute Kidney Injury

First Posted Date: 2022-04-25

Last Posted Date: 2024-11-21

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 66

Registration Number: NCT05344573

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

PCOM2 - The Physician Communication Intervention, Version 2.0

Not Applicable

Recruiting

Conditions: Preventive Health Services
HPV Infection

Interventions: Behavioral: Physician Communication Standard (PCOM-standard)
Behavioral: Physician Communication 2 Virtual (PCOM2-virtual)

First Posted Date: 2022-04-20

Last Posted Date: 2024-08-26

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 120

Registration Number: NCT05336240

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
🇺🇸
University of Kansas Medical Center, Wichita, Kansas, United States

Implementing Continuous Glucose Monitoring in Primary Care for Patients With Diabetes

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2
Diabetes Mellitus, Type 1
Continuous Glucose Monitoring

Interventions: Other: Virtual CGM initiation service
Other: Online educational module on CGM
Other: Practice facilitation

First Posted Date: 2022-04-20

Last Posted Date: 2024-12-10

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 190

Registration Number: NCT05336214

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

Adherence and Clinical Correlates in Persons With HIV on TAF

Active, not recruiting

Conditions: Hiv

First Posted Date: 2022-04-19

Last Posted Date: 2024-08-27

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 384

Registration Number: NCT05335590

Locations: 🇺🇸
University of Colorado Health, Aurora, Colorado, United States

Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)

Recruiting

Conditions: Type 1 Diabetes
Diabetic Nephropathies
Diabetes Complications
Diabetic Kidney Disease
Autoimmune Diabetes

Interventions: Drug: Aminohippurate Sodium Inj 20% Diagnostic aid/agent used to measure effective renal plasma flow (ERPF)
Drug: Iohexol Inj 300 MG/ML Diagnostic aid/agent used to measure glomerular filtration rate (GFR)

First Posted Date: 2022-04-11

Last Posted Date: 2024-04-10

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 100

Registration Number: NCT05319990

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

Reducing Disparities in Rural HIV Prevention

Not Applicable

Completed

Conditions: HIV Infections
Sexually Transmitted Infections

Interventions: Other: Virtual clinical visits with home lab kits and mailed HIV PrEP

First Posted Date: 2022-04-08

Last Posted Date: 2024-04-01

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 69

Registration Number: NCT05319613

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

Effects of DHEA and Exercise on Bone Marrow Fat in Postmenopausal Women

Not Applicable

Completed

Conditions: Osteoporosis
Low Bone Density

Interventions: Behavioral: Exercise
Dietary Supplement: DHEA

First Posted Date: 2022-04-07

Last Posted Date: 2024-12-10

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 41

Registration Number: NCT05316272

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

Rapid Blood Culture Identification Panel in Pediatric Patients in Guatemala

Not Applicable

Completed

Conditions: Bacteremia
Sepsis

Interventions: Diagnostic Test: Blood culture identification panel

First Posted Date: 2022-04-06

Last Posted Date: 2024-06-14

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 479

Registration Number: NCT05314816

Locations: 🇬🇹
Hospital Roosevelt, Guatemala City, Guatemala

Reducing Pain and Opioid Use With CBD

Phase 2

Recruiting

Conditions: Opioid Use Disorder

Interventions: Drug: Placebo
Drug: Cannabidiol

First Posted Date: 2022-03-29

Last Posted Date: 2024-10-01

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 150

Registration Number: NCT05299944

Locations: 🇺🇸
University of Colorado - Anschutz Medical Campus, Aurora, Colorado, United States
🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo

Phase 2

Completed

Conditions: Vitiligo

Interventions: Drug: Crisaborole 2 % Topical Ointment
Drug: PF-07038124 0.01% topical ointment
Device: NBUVB phototherapy
Device: Sham phototherapy
Drug: Vehicle

First Posted Date: 2022-03-28

Last Posted Date: 2024-06-12

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 32

Registration Number: NCT05298033

Locations: 🇺🇸
University of Colorado Anschutz - Clinical and Translational Research Centers, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy